Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page revision/version updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:24:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:41:32.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; there are no visible edits to the study details content.
    Difference
    0.1%
    Check dated 2026-03-21T16:52:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T13:19:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions list. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T17:32:06.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added primary peritoneal carcinoma to the conditions and included the Genetic and Rare Diseases Information Center under resources. Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T11:35:40.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.